Business Description
Oxford Biomedica is a UK-based company that develops and manufactures gene therapies on behalf of pharmaceutical and biotechnology clients around the world. The company specializes in viral vector technologies, including its own proprietary platforms for lentiviral and AAV-based gene delivery, which are designed to improve safety and performance over older approaches. Founded in 1996 and headquartered in Oxford, England, Oxford Biomedica supports its partners across the full journey from early development through to large-scale manufacturing.
